-

Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade MM+M has named Danielle Lynch, Vice President, Client Experience, to its Women to Watch class of 2022.

Now in its seventh year, the program recognizes successful leaders and up-and-coming talent in the industry who have inspired their colleagues, showcased new ways of doing business and taken healthcare marketing to new heights. Lynch was chosen as one of just 25 women to receive this year’s honors.

“I’m honored to be recognized by MM+M alongside such esteemed women leaders in the healthcare marketing field,” Lynch said. “I’m incredibly proud of the Phreesia Life Sciences team and the success we’ve achieved through hard work and collaboration.”

Since playing a pivotal role in taking Phreesia public in 2019, Lynch has doubled the size of her team and helped increase Life Sciences revenue by nearly 100%. She is admired by her colleagues for her innovation, tenacity, and her continued contributions to Phreesia's mission of creating a better, more engaging healthcare experience.

“We are thrilled to see Danielle awarded this well-deserved honor,” David Linetsky, Phreesia’s Senior Vice President, Life Sciences, said. “Danielle built the Client Experience team—the engine behind Phreesia Life Sciences’ significant growth—from the ground up, and her vision and leadership have been instrumental to the team’s success.”

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering targeted health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, and our PatientInsights product enables our clients to better understand their target patient populations.

Phreesia meets patients where they are, both virtually and in-person, and reaches them at multiple touchpoints throughout their healthcare journey. To learn more about Phreesia Life Sciences, visit lifesciences.phreesia.com.

Contacts

Media Contact:
Carly Helfand
chelfand@phreesia.com
332-910-6768

Phreesia

NYSE:PHR

Release Versions

Contacts

Media Contact:
Carly Helfand
chelfand@phreesia.com
332-910-6768

More News From Phreesia

Phreesia Announces First Quarter Fiscal 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2026. “Phreesia had a solid first quarter to build on in fiscal 2027. We entered the new fiscal year with an experienced team, a strong financial profile and continued momentum across several key initiatives, including positioning AccessOne for future growth, the successful launch of our healthcare provider...

Phreesia Sets Release Date for Fiscal First Quarter 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026....

Phreesia Named to Becker’s Hospital Review’s 2026 List of “Revenue Cycle Management Companies to Know”

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to Becker’s Hospital Review’s 2026 list of “Revenue Cycle Management Companies to Know.” The annual list recognizes companies that play a critical role in helping healthcare organizations manage the growing complexity of revenue cycle operations, including patient access, intake, billing and reimbursement. The 2026 list highlights organizations driving innovation a...
Back to Newsroom